diphenhydramine has been researched along with ketorolac in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Beyer, JE; Jacob, E; Miaskowski, C; Savedra, M; Styles, L; Treadwell, M | 1 |
| Adewunmi, V; Bijur, PE; Campbell, C; Esses, D; Friedman, BW; Gallagher, EJ; Solorzano, C | 1 |
| Gerard, JM; Kaar, CR; Nakanishi, AK | 1 |
| Hershey, AD; Kabbouche, M; Maconochie, I; Murphy, B; Qaiser, S; Werner, K | 1 |
| Desai, L; Farooqi, A; Kannikeswaran, N; Sivaswamy, L | 1 |
2 review(s) available for diphenhydramine and ketorolac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Intravenous Migraine Treatment in Children and Adolescents.
Topics: Administration, Intravenous; Adolescent; Akathisia, Drug-Induced; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Basal Ganglia Diseases; Child; Dexamethasone; Dihydroergotamine; Diphenhydramine; Dopamine Antagonists; Emergency Service, Hospital; Enzyme Inhibitors; Fluid Therapy; Glucocorticoids; Hospitalization; Humans; Hypnotics and Sedatives; Ketorolac; Lidocaine; Magnesium; Migraine Disorders; Prochlorperazine; Propofol; Valproic Acid; Vasoconstrictor Agents | 2020 |
1 trial(s) available for diphenhydramine and ketorolac
| Article | Year |
|---|---|
A randomized trial of intravenous ketorolac versus intravenous metoclopramide plus diphenhydramine for tension-type and all nonmigraine, noncluster recurrent headaches.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diphenhydramine; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Ketorolac; Male; Metoclopramide; Middle Aged; Pain Management; Pain Measurement; Recurrence; Tension-Type Headache | 2013 |
10 other study(ies) available for diphenhydramine and ketorolac
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Management of vaso-occlusive pain in children with sickle cell disease.
Topics: Adolescent; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Diphenhydramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Ischemia; Ketorolac; Longitudinal Studies; Male; Morphine; Pain; Pain Management; Pain Measurement; Patient Satisfaction; Self Administration; Treatment Failure | 2003 |
The Use of a Pediatric Migraine Practice Guideline in an Emergency Department Setting.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dihydroergotamine; Diphenhydramine; Emergency Service, Hospital; Female; Guideline Adherence; Humans; Hypnotics and Sedatives; Ketorolac; Length of Stay; Male; Metoclopramide; Migraine Disorders; Pain Management; Pain Measurement; Practice Guidelines as Topic; Prochlorperazine; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Effectiveness of Standard Combination Therapy in Pediatric Migraine.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diphenhydramine; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Ketorolac; Male; Migraine Disorders; Outcome Assessment, Health Care; Prochlorperazine; Prospective Studies; Saline Solution | 2021 |